Rewire Neuro, Inc. improves the speed and accuracy of biomedical image analysis with a direct-to-researcher implementation of our cloud-based computer vision platform. Additionally, custom integrations of our patented AI engine enable automated biomarker detection in partnering environments. Rewire’s AI is used by hundreds of customers world-wide and through multiple established partnerships. Rewire has raise over $3 million in private investment, federal grants, and state funding.
You must be logged in to post a comment.